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Background: Mild head injuries commonly present to emergency departments. The challenges facing clinicians in
emergency departments include identifying which patients have traumatic brain injury, and which patients can
safely be sent home. Traumatic brain injuries may exist with subtle symptoms or signs, but can still lead to adverse
outcomes. Despite the existence of several high quality clinical practice guidelines, internationally and in Australia,
research shows inconsistent implementation of these recommendations. The aim of this trial is to test the
effectiveness of a targeted, theory- and evidence-informed implementation intervention to increase the uptake of
three key clinical recommendations regarding the emergency department management of adult patients (18 years
of age or older) who present following mild head injuries (concussion), compared with passive dissemination of
these recommendations. The primary objective is to establish whether the intervention is effective in increasing the
percentage of patients for which appropriate post-traumatic amnesia screening is performed.
Methods/design: The design of this study is a cluster randomised trial. We aim to include 34 Australian 24-hour
emergency departments, which will be randomised to an intervention or control group. Control group departments will
receive a copy of the most recent Australian evidence-based clinical practice guideline on the acute management of
patients with mild head injuries. The intervention group will receive an implementation intervention based on an analysis
of influencing factors, which include local stakeholder meetings, identification of nursing and medical opinion leaders in
each site, a train-the-trainer day and standardised education and interactive workshops delivered by the opinion leaders
during a 3 month period of time. Clinical practice outcomes will be collected retrospectively from medical records by
independent chart auditors over the 2 month period following intervention delivery (patient level outcomes). In consenting
hospitals, eligible patients will be recruited for a follow-up telephone interview conducted by trained researchers.
A cost-effectiveness analysis and process evaluation using mixed-methods will be conducted. Sample size calculations are
based on including 30 patients on average per department. Outcome assessors will be blinded to group allocation.
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Head injuries are a frequent presentation to emergency
departments (EDs) worldwide. They are caused by exter-
nal forces to the head (such as sport, falls, motor vehicle
accidents, assaults or blast injuries) [1]. Country-based
incident estimates range from 108 to 332 hospitalised new
cases per 100,000 population per year [2], and the inci-
dence is rising as a consequence of increased transport-
related injuries in low- and middle-income countries [1].
Traditionally, head injuries are classified as mild, moderate
or severe head injury, depending on the patient’s present-
ing level of consciousness as expressed by the Glasgow
Coma Scale (GCS) score [3]. The scale ranges from a low
of 3 (comatose) to 15 (awake and following commands).
The vast majority of patients (80 to 90% depending on
definitions) present with normal or near normal GCS
scores (14-15/15) and are therefore classified as “mild”. In
non-paediatric patients, the highest incidence of mild
traumatic brain injury (mTBI) is seen in males between
the ages of 15 and 24 years and in men and women
65 years of age and older [4].
In most cases, patients who experience mTBI will
recover fully, typically within days to months. Up to
15% of patients with a normal GCS score of 15 have an
acute lesion on head computed tomography (CT), but
less than 1% of these patients have a lesion that re-
quires neurosurgical intervention [4-6]. However, up to
15% of patients diagnosed with mTBI experience persist-
ent disabling problems [7,8] including reduced functional
ability, heightened emotional distress, and delayed return
to work or school [9,10] 3 months or more after injury. As
the ED is the main, and often only, point of medical con-
tact for these patients, ED care may provide opportunities
to impact on the outcomes of these patients.
The challenge for the emergency physician is to iden-
tify which patients with a head injury have an actual
traumatic brain injury (TBI) requiring further manage-
ment, and which patients can safely be sent home [4].
Patients with subtle symptoms or signs can still progress to
suboptimal outcomes [4]. Despite the existence of several
high quality evidence-based clinical practice guidelines
(EBCPGs) internationally and in Australia [11], research
shows inconsistent implementation of recommended
practices. In earlier phases of our study, relevant EBCPGs
were identified and assessed for their quality [11]. Subse-
quently, key clinical recommendations and the evidence
underpinning these recommendations were studied, andtwo consensus meetings were organised to develop locally
relevant recommendations to serve as the basis for devel-
oping our management outcome measures [12]. Table 1
outlines the evidence-based recommendations, their
relevance to the management of this patient group, and
evidence regarding gaps in practice.
We are not aware of trials which have evaluated im-
plementation of this suite of recommendations in ED
practice internationally or in Australia. A cluster ran-
domised trial (CRT) performed by Stiell and colleagues
[29] in Canada implemented the Canadian CT Head
Rule (CCTHR) to reduce unnecessary CT scans. Their
implementation intervention package included edu-
cation (distribution of articles describing the deve-
lopment and validation of the rule, pocket cards and
posters, and a 1-hour teaching session to review the
evidence and clinical application of the rule), and a
mandatory real-time reminder of the rule at the point
of CT scan request that required checking off the rule
before the scan would be performed by the imaging
department [29]. The intervention was designed to be
low-cost and simple and had been shown to be effective in
reducing cervical spine imaging rates for neck trauma in a
simultaneous study [44]. In the implementation of the
CCTHR, the intervention failed to reduce the number of
CT scans requested; in fact, CT imaging rates increased
in both intervention and control group (62.8% before
compared with 76.2% after, absolute difference +13.3%,
and 67.5% to 74.1%, absolute difference +6.7%, respect-
ively; a difference in change between groups of 6.6%).
However, the baseline rates were much lower than ex-
pected and approaching the estimated ‘safe’ rate (62.4%),
which may have reduced the likelihood of further reduc-
tions (that is, indication of a ceiling effect) [29].
Increasingly it is considered best practice to base
interventions aiming to change clinical practice on a
theoretical approach to identifying factors potentially
influencing practice change [45]. Theory can offer a gener-
alisable framework for considering effectiveness across dif-
ferent clinical conditions and settings [46], and, given the
wide variety of factors that may influence practice change,
basing interventions on different theoretical assumptions
may prevent overlooking important factors [47] and will
ultimately help to understand how and why change is
achieved. Additionally, this approach offers the possibil-
ity of optimising interventions to increase effect sizes in
subsequent studies.
Table 1 Key clinical recommendations in the management of mild traumatic brain injury in emergency departments
Key recommendations and relevance to management Research highlighting the ‘evidence-practice’ gap
Post-traumatic amnesia should be prospectively assessed in the emergency department using a validated tool
Post-traumatic amnesia (PTA) is defined as "an interval during which the patient is confused, amnestic for
ongoing events and likely to evidence behavioural disturbance" [13]. It may manifest as repetitive
questioning or short-term memory deficits [14] and has been shown to have better predictive ability
with clinical outcomes compared with Glasgow Coma Scale (GCS) [15-18] (GCS assesses consciousness
but not whether the patient is able to lay down new memories). Various validated tools to asses PTA
are available such as the Revised Westmead PTA tool, or the Abbreviated Westmead PTA scale (A-WPTAS),
the latter being an extended version of the GCS and specifically developed for use in the emergency
department (ED). The A-WPTAS standardises some of the questions of the GCS and adds a memory test.
Screening for PTA using such a validated tool may reduce the risk of failing to classify mild traumatic brain
injury (mTBI) patients and prevents patients from being discharged from hospital while they are suffering
from acute cognitive impairment [19,20].
A retrospective audit in two Australian EDs showed rates of assessment of PTA in
adults (for those with an initial GCS of 14 or 15) as 0% (95% CI 0% to 14%; n = 24)
in one hospital, and 31% (95% CI 24% to 39%; n = 164) for a second (which had a
protocol in place) (Bosch M, McKenzie J, unpublished observations). We are not
aware of any published studies reporting rates in adults.
Guideline-developed criteria or clinical decision rules should be used to determine the appropriate use and
timing of computed tomography imaging
The aims of using clinical decision rules to determine the need for a computed tomography (CT) scan are
to ensure patients at risk of developing intracranial injuries receive a scan, and to decrease unnecessary
scanning. Several clinical decision rules have been developed worldwide, some of which have been externally
validated, most notably the Canadian Computed Tomography Head Rule (CCTHR) [21] and the New Orleans
Criteria [22]. However, both these rules used loss of consciousness or amnesia as entry criteria, which means
they could not be reliably used for all patients presenting to the ED with a head injury. Studies show that
intracranial complications can also occur without loss of consciousness/PTA, particularly in the presence of
other risk factors [23-25]. Therefore, more recent guidance has been developed that is applicable to all patients
irrespective of presence or absence of loss of consciousness/PTA [4,14,26]. Most evidence-based clinical practice
guidelines for the management of patients with mTBI have adapted one or more of these rules. They show
considerable concordance [27]. The Institute for Trauma and Injury Management, New South Wales, developed
simple recommendations for the identification of high risk patients based on the presence of single criteria that
are applicable in the Australian setting [14].
It is difficult to establish target rates for appropriate CT scanning in patients with
mTBI (that is, the percentage of mTBI patients who should receive a scan)
because this is dependent on the case mix of patients (for example, hospitals that
service an older demographic may (appropriately) have higher CT scanning rates
for mTBI patients) and the leniency of the rules or guidelines. A study comparing
percentages of scans that would be required by applying six different rules found
rates between 50% and 71% [28]. A Canadian study using the CCTHR estimated a
rate as low as 62.4% was possible and safe [29].Estimates of how frequently
appropriate decisions are made about the need for CT scanning (in populations
with slightly variable definitions and using several different rules) range from 66%
in the UK [30], 73% in Scandinavia [31], 82.5% in Canada [29], 80% and 92% in
indigenous and non-indigenous Australians [32], and 65% to 91% in the US [33].
A study [34] surveying Australian ED physicians (response rate 54.2%, n = 417)
showed that 82% had awareness of CCTHR but only 32% used it.
Verbal and written patient information consisting of advice, education and reassurance should be provided
upon discharge from the emergency department
Providing patients with information upon discharge serves two purposes: 1) to inform the family/carer about
what to observe and what actions to take if the patient’s neurologic condition deteriorates significantly after
discharge from the ED [35]; and 2) to provide information regarding post-concussive symptoms, symptom
management, and prevention of future head injuries [36-39]. A randomised controlled trial [40] of 202 adults
with mTBI in Australia evaluated the impact of patient information (booklet) on outcomes. The booklet outlined
common symptoms associated with mTBI, their likely time course and suggested coping strategies. By 3 months,
the intervention group had lower scores on most items on a post-concussion checklist, significantly so for anxiety
(P < 0.04) and sleeping difficulty (P < 0.01). They also had lower scores on a ‘global severity’ score. There was no
statistical difference between the groups on formal neuropsychological assessment.
Studies show that a large proportion of mTBI patients do not receive written
information upon discharge from the ED, ranging from 36% [41] and 51% [30] in
the UK, to 63% in the US [42]. Studies looking at the quality and content of
discharge pamphlets [35,37,38,43] found that the information regarding
post-concussive symptoms and reassurance is missing in 41% [37] to 60% [38] of
pamphlets reviewed. One study surveyed nurses (25% response rate) regarding
their teaching habits [36], and concluded that in general they were more focused
on providing injury-specific information and less on mTBI, symptom management
or strategies to prevent future brain damage.
Bosch
et
al.Trials
2014,15:281
Page
3
of
20
http://w
w
w
.trialsjournal.com
/content/15/1/281
Bosch et al. Trials 2014, 15:281 Page 4 of 20
http://www.trialsjournal.com/content/15/1/281Aims and objectives
The aim of this trial, which is part of the Neurotrauma
Evidence Translation (NET) programme [48], is to test the
effectiveness of a targeted, theory- and evidence-informed
implementation intervention to increase the uptake of
three key clinical EBCPG recommendations regarding the
management of adult patients (18 years of age or older)
who present to Australian EDs with mild head injuries,
compared with passive dissemination of the EBCPG.
More specifically, the primary objective is to establish
whether the intervention is effective in increasing the
percentage of patients for which a prospective measure
of post-traumatic amnesia (PTA) using a validated tool
is performed in the ED until a perfect score is achieved
or the patient is transferred or admitted.
Secondary objectives include establishing whether the
intervention is effective in: increasing the percentage of
patients for which two other assessment methods of
PTA were performed (assessment without using tool,
and whether the administration of the validated tool
was completed at least once); increasing the percentage
of patients for which CT scanning is appropriately
performed; increasing the percentage of patients who
receive patient information upon discharge home from
the ED; changing factors that are thought to mediate
the effect of the intervention (such as increasing
the staff members’ knowledge, or decreasing negativeFigure 1 Trial design. EBCPG, evidence-based clinical practice guideline; Ebeliefs about consequences); and improving selected
patient clinical outcomes and quality of life.
In addition, our study aims to: quantify the trade-off
between the hypothesised improvement in patient manage-
ment and patient health outcomes, and the additional costs
(savings) arising from delivery of the implementation in-
tervention and from any subsequent changes in clinical
practice and healthcare utilisation by conducting a cost-
effectiveness analysis; and evaluate intervention fidelity,
assess acceptability of the intervention, and assess percep-
tions around success of the implementation processes and
influencing factors, by conducting a process evaluation.
Methods/design
The design of this study is a CRT, with the EDs being the
clusters including the ED staff members involved in the
treatment of patients with mTBI and the patients treated.
A randomised design is the preferred one to evaluate the
effectiveness of an intervention since it minimises bias in
estimating intervention effects compared with other study
designs [49,50]. In this study, clusters (hospital EDs) have
been chosen for two reasons: the intervention is targeted
at the team of ED staff, and EDs represent patient popula-
tions in geographical areas, precluding the use of an indi-
vidually randomised design [51,52].
The study has two levels of participation (Figure 1):
NET and NET-Plus. NET will measure clinical practiceD, emergency department; NET, Neurotrauma Evidence Translation.
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will include both. These two options will be offered to
hospitals because we anticipate that some may prefer
not to recruit patients.
Recruitment and eligibility
Recruitment of emergency departments and inclusion/
exclusion criteria
The sampling frame for this study will be derived from
the Australasian Society for Emergency Medicine ED
Directory list of 24-hour Australian EDs (regional and
metropolitan) [53]. EDs involved in the pilot and/or
development of the intervention will not be invited to
participate in the trial.
Hospitals will be included if we receive written informed
consent from the ED Director to randomise the ED to con-
trol or intervention group. Hospitals will be excluded if
they are either non-24-hour EDs or specialised hospitals
(for example, women’s or children) and do not therefore
routinely treat adult patients with TBI. In addition, EDs will
be excluded if they do not have a CT scanner on site, or if
there is significant risk of bias (for example, risk of con-
tamination due to two EDs having the same ED Director,
or senior influential clinicians working across sites).
We intend to recruit 34 EDs (see sample size section).
Based on a previous Australian study (Knott J, Bosch M,
personal communications) which observed a 50% ED
participation rate, we plan to initially invite 68 randomly
selected hospitals to participate in the trial. Our recruit-
ment strategy will follow recommendations regarding
the recruitment for CRTs in secondary care settings [52].
ED directors will be considered ‘gatekeepers’ (people
who can grant formal permission for the organisation to
be involved) of the clusters. As a first step they will be
contacted by telephone to inform them about the study,
and let them know that they will receive a recruitment
pack (including an invitation letter from the research
team, explanatory statement, and an expression of inter-
est form). The ED Director will be encouraged to discuss
the trial with the relevant stakeholders within their ED
(in particular Directors of Trauma or staff members
responsible for trauma and/or research, and senior clini-
cians). Upon receipt of the expression of interest, a
recruitment meeting will be organised (via telephone,
skype, video-link or face-to-face) with the study investi-
gators and the relevant stakeholders in the ED. During
this recruitment meeting, the details and logistics of
the study will be discussed. Following this meeting, the
ED Director will be asked to provide written informed
consent to trial entry (either NET or NET-Plus), using
a consent form sent prior to the meeting [51,52,54].
Non-responders will be followed up by email and tele-
phone [55] at least once, before inviting the next ran-
dom selection of hospitals.The content of the recruitment information will be
designed to target factors influencing the decision to
participate in this trial [56] that were identified in semi-
structured interviews in an earlier phase of this study
(for example, by providing information around resources
and including information around the benefits for the
patients to create ‘tension for change’). In addition, pro-
fessional bodies will be engaged to endorse the trial [57].
Recruitment of emergency department staff members for
data collection purposes and inclusion/exclusion criteria
ED medical and nursing staff will be invited to complete
two questionnaires (at baseline and endpoint). The sam-
pling frame for staff participants will be based on the active
list of ED medical and nursing personnel in each ED.
Inclusion criteria for nursing staff are: 1) current ED
appointment; 2) on active practice roster; 3) enrolled or
registered nurses. Inclusion criteria for medical staff are: 1)
current ED appointment; 2) on active practice roster; 3)
registrars, Hospital Medical Officers or consultants. For
both groups, exclusion criteria are: 1) students/interns; 2)
clinicians not currently engaged in clinical practice (for ex-
ample, academic staff); and 3) for nurses, bank or agency
nurses.
We plan to randomly select 50 eligible ED clinicians per
clinical group per hospital (that is, 100 in total) when avail-
able at baseline and endpoint. For hospitals with fewer than
50 clinicians per clinical group, we plan to invite all clini-
cians satisfying the inclusion criteria to participate for data
collection. Staff members who were contacted at baseline
will be asked to participate at endpoint, and additional staff
will be randomly selected in instances where staff have been
lost to follow-up. Staff members will be included if they fit
our inclusion criteria and consent to participate.
In addition, some key staff members in eight interven-
tion sites will be recruited to participate in a brief evalu-
ation interview over the telephone. To identify staff, we
will use a key-informant method [58].
Finally, all ED Directors or their delegate will be in-
vited to complete two brief checklists over the telephone
regarding ED characteristics at baseline and endpoint.
Identification of study patients and inclusion/exclusion
criteria
In order to determine the effect of the intervention on
clinical practice outcomes, a chart audit will be con-
ducted by independent chart auditors. Patients are eli-
gible if they are aged 18 years or older, present to the
ED within 24 hours following acute blunt head trauma,
and have a GCS score of 14 or 15 at presentation [14].
Exclusion criteria include penetrating injuries, and non-
traumatic TBI such as caused by stroke.
A patient identification protocol will be developed and
chart auditors will be trained with the aim of maximising
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selective recruitment. We anticipate that patients will be
identified retrospectively from clinical records using med-
ical codes (for example, relevant International Statistical
Classification of Diseases and Related Health Problems
Tenth Revision, Australian Modification (ICD-10AM) dis-
charge codes). Instructions will be piloted and tailored to
the hospital medical record system. As there may be some
between-hospital variation in the approach taken, the exact
process to identify patients will be carefully recorded in
each hospital.
Recruitment of patients for follow-up – NET-Plus only
In hospitals which choose to participate in NET-Plus,
patients included in the chart audit will be contacted by
telephone by an ED staff member to invite them to par-
ticipate in a follow-up telephone interview questionnaire
by trained researchers. Informed consent to pass on
their contact details to the NET research team will be
sought (see ethical review and informed consent).
For this component, additional exclusion criteria are:
1) not consenting to participate in the follow-up study;
and 2) not being able to participate in a telephone inter-
view, because of an inability to speak English, being
hearing-impaired, or having cognitive or intellectual im-
pairment (history of dementia, other neurological dis-
order, intellectual disability drug or alcohol abuse or
other major psychiatric disorder such as psychosis for
which hospitalisation has been required).
These criteria will be confirmed by the ED staff asking
for consent and again by the trained researcher at the
start of the interview.
Randomisation and allocation concealment
EDs will be allocated to the intervention and control
groups using the method of minimisation proposed by
Pocock and Simon [59]. Minimisation has been shown
through statistical simulation studies to outperform
stratified allocation methods for maintaining baseline
balance in prognostic factors [60]. In addition, the method
allows for balancing across a greater number of prognostic
factors. The minimisation factors will include: the ex-
istence of a protocol for mTBI (consistent with our rec-
ommendation for appropriate PTA assessment); size
(annual presentation rate 2012), included as a proxy for
other variables that are harder to measure such as staffing;
rurality; and type of participation (NET or NET-Plus).
Minimisation is essentially a deterministic method [60],
and therefore use of this method can increase the risk
of selection bias [61]. We plan to reduce the risk of
selection bias through inclusion of a random compo-
nent and allocation of batches of EDs by a statistician
independent of the trial. The statistician will be provided
with a file containing only ED codes and the minimisationfactors (thus no identifying information). For each batch
of EDs, the statistician will randomise the order of EDs
before using the minimisation algorithm to allocate the
EDs to intervention and control groups.
Blinding
Due to the nature of the intervention, it will not be pos-
sible to blind ED staff members to group allocation. To
limit the possibility of selection and detection bias,
chart auditors will be independent, where possible, of
the hospital. In instances where the hospital does not
approve an independent chart auditor, a solution will be
discussed which aims to reduce the risk of selectively
identifying patients (for example, using a staff member
from another unit who will receive training from the
research team). External chart auditors and the trial
statistician will be blinded to group allocation.
Interventions
Intervention group
Intervention group EDs will receive a targeted, theory-
and evidence-informed implementation intervention.
The intervention builds upon the previous phases of this
study. In phase one, relevant EBCPGs were identified,
assessed for their quality, and the focus of the study was
determined [11,12]. In phase two, semi-structured inter-
views underpinned by theoretical perspectives on indi-
vidual and organisational change were conducted with
42 ED staff members in 13 Victorian EDs. Thematic
analysis was used to identify the factors perceived to be
influencing current practice as well as change in the ED
setting. In phase three, our intervention was developed
to address the modifiable influencing factors to maxi-
mise the effectiveness of the intervention. Intervention
components were piloted for feasibility and acceptability.
Table 2 summarises the content of the intervention.
Only broad components are described in this protocol
to prevent contamination of the control group. The
process of development of the intervention and a de-
scription of its content will be published in detail post-
data collection.
Control group
Control EDs will receive a copy of the EBCPG [14] and
all the materials/components needed for the outcome
assessment. Post-data collection, control EDs will be
invited to a repeat train-the-trainer 1-day interactive
workshop where they will also receive the components
for the local education and all other intervention
materials.
Timing of recruitment, intervention delivery, and follow-up
Figure 1 shows the flow of an ED through the trial.
We started recruitment and completion of ethics and
Table 2 Planned delivery of the intervention
Intervention and control group
1. An electronic/printed copy of Initial Management of Closed Head
Injury in Adults guideline [14].
2. Data collection reminder sticker/flag in system and education
around the importance of documenting information for mild
traumatic brain injury patients to optimise data collection.
Intervention group only
3. One hour face-to-face multidisciplinary stakeholder meeting in each
participating hospital with key stakeholders (both clinical and change
management) and senior Neurotrauma Evidence Translation (NET)
clinicians and researcher to create buy-in at ‘organisational’ level for
the changes by discussing the key recommendations and underlying
evidence; discussing intervention components and how to overcome
anticipated barriers in their implementation etc.
4. Identification of multidisciplinary local opinion leader team (medical
and nursing) via key-informant method [58] (emergency department
Directors will be provided with a description of the types and
characteristics of people suited to the role).
5. One day train-the-trainer interactive workshop, led by content
experts and senior NET clinicians, attended by the nursing and
medical opinion leaders, consisting of information provision and
skills training - both in relation to the key-recommendations as well
as in relation to their role in the study.
6. Delivery of materials for local workshops (brief 20 minute sessions) in
relation to the key recommendations presented by the clinical
opinion leaders to staff in their emergency department over a
3 month period of time.
7. Provision of relevant tools and materials (for example, screening
tools [14] and information booklets [40] translated into five
languages that are commonly spoken in Australia).
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line data collection has commenced (October 2013).
Intervention delivery and endpoint data collection will
take place in 2014.
Study outcomes and outcome measurement
Tables 3 shows our clinical practice outcomes and data
collection methods.
Primary outcome
Our primary outcome is ‘appropriate PTA screening’
(PTA; Table 3). This outcome measures whether a pro-
spective assessment of PTA was appropriately under-
taken, where appropriately undertaken is defined as
using a validated tool, until a perfect score was achieved
(indicating absence of acute cognitive impairment) be-
fore the patient was discharged home (or the patient was
admitted or transferred). This measure has been chosen
as the primary outcome for the following reasons. First,
PTA has been shown to have better predictive ability
with clinical outcomes compared with GCS [15-18]. Many
patients are oriented by the time they are first assessed,
and therefore achieve the top score on the GCS scale,
which leads to the common misperception that a perfect
score means a normal examination [62]. Ponsford andcolleagues conceptualised the Revised Westmead PTA
Scale for screening of PTA in patients with mTBI, identi-
fying it as more sensitive to the presence of PTA than
GCS [63]. Shores and colleagues [17] studied the diagnos-
tic accuracy of the Revised Westmead PTA scale and
showed that at the time of the second neurological obser-
vation 60% of participants were not able to lay down new
memory; yet 87% of them had been assigned a GCS of 15.
Another recent study [15] showed that whereas patients
with GCS scores of 13 or 14 did not differ from those with a
score of 15 with respect to neuroimaging abnormalities, pa-
tients who had experienced PTA for more than 30 minutes
were more likely to have intracranial abnormalities on im-
aging. So, by using a validated tool as part of the neuro-
observations until patients receive an optimal score, one
reduces the risk of failing to classify mTBI patients and pre-
vents patients from being discharged from hospital while
they are suffering from acute cognitive impairment [19,20].
Second, this outcome can be reliably measured (the
score is an objective measure in the medical records).
Finally, given the estimated low rate of appropriate PTA
screening (see sample size section), there is considerable
opportunity for improvement.
Secondary outcomes
Clinical practice outcomes Two other measures for PTA
were selected as secondary outcomes. ‘PTA screening-tool’
measures whether the administration of the validated tool
was completed at least once. ‘Memory-clinical’ measures
whether staff members have made an assessment of
memory using questions in their clinical assessment.
Other secondary measures assessing the effectiveness of
the intervention in improving the ED management of
mTBI are listed in Table 3. On the cohort of patients for
whom risk criteria are recorded, ‘CT scan-clinical cri-
teria’ (CT) measures whether a CT scan was provided in
the presence of a risk factor that justifies the scan (see
Additional file 1). This measure is therefore indicating
whether a scan was appropriately received; however, we
will not be able to measure whether a scan was ‘appropri-
ately denied’ because of the inconsistency in recorded
clinical criteria. ‘Provision of patient information’ (INFO)
measures whether information was recorded as provided
upon discharge home from the ED. Via the chart audit, we
will not be able to measure what information was handed
out (for example, the information used in our intervention
[40] or other). However, this will be assessed in the patient
follow-up interview in NET-Plus hospitals. Two measures
of ‘safe discharge’ are included, the first being a composite
score of PTA and INFO (for all patients), and the second
provides a composite measure of whether the patient re-
ceived appropriate care for all of the three clinical prac-
tices (PTA, CT, INFO; for the subgroup of people for
whom risk criteria were recorded).
Table 3 Clinical practice and proxy clinical practice outcomes and data collection methods
Method Outcome assessment
period/timing
Data source Level data
collected
Analysis
level
Primary outcome
Appropriate post-traumatic
amnesia screening (PTA)
Chart audit (retrospective) 2 month period
post-intervention
Hospital record Patient Patient
Secondary outcomes
Clinical practice outcomes
PTA screening tool Chart audit (retrospective) 2 month period
post-intervention
Hospital record Patient Patient
Memory - clinical assessment Chart audit (retrospective) 2 month period
post-intervention
Hospital record Patient Patient
Computed tomography
scan - clinical criteria (CT)1
Chart audit (retrospective) 2 month period
post-intervention
Hospital record Patient Patient
Provision of patient information (INFO) Chart audit (retrospective) 2 month period
post-intervention
Hospital record Patient Patient
Safe discharge based on PTA and INFO Chart audit (retrospective) 2 month period
post-intervention
Hospital record Patient Patient
Safe discharge based on PTA, CT,
and INFO
Chart audit (retrospective) 2 month period
post-intervention
Hospital record Patient Patient
Proxy measures of clinical practice
Self-report of adherence to
recommended practice
• PTA Staff questionnaire (1-item) Baseline/Endpoint Doctors Staff member Staff member
Nurses
• CT Staff questionnaire (1-item) Baseline/Endpoint Doctors Staff member Staff member
• INFO Staff questionnaire (1-item) Baseline/Endpoint Doctors Staff member Staff member
Nurses
Behavioural simulation2 to adhere
to recommended practice
• PTA Staff questionnaire
(clinical vignettes)
Endpoint Doctors Staff member Staff member
Nurses
• CT Staff questionnaire
(clinical vignettes)
Endpoint Doctors Staff member Staff member
Nurses
• INFO Staff questionnaire
(clinical vignettes)
Endpoint Doctors Staff member Staff member
Nurses
1Criteria that justify a scan are: age 65 years or older; GCS <15; amnesia; suspected skull fracture; vomiting and coagulopathy (see Additional file 1). 2Clinical
decision in response to individual simulated patients, for example in patient scenarios.
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ively through chart audit by an independent, trained chart
auditor. Data will be collected over the 2 month period
following the last intervention component.
Proxy measures of clinical practice Secondary out-
comes also include proxy measures of the clinical practices
of interest. These proxy measures consist of self-report
measures and clinical vignettes [64].
Predictors of clinical practices Table 4 shows the fac-
tors we hypothesise to mediate the intervention effects,
listed per clinical practice. Factors have been grouped into
two categories: 1) collective level constructs – clinicians’self-reported cognitions about their EDs team climate
for innovation [65,66] in relation to the clinical manage-
ment of mTBI in general; and 2) individual level con-
structs – clinicians’ self-reported cognitions in relation
to each clinical practice (such as the extent to which the
clinicians feel confident in screening for PTA using a
validated tool (beliefs about capabilities), whether a
clinician believes these clinical practices will lead to
favourable outcomes (beliefs about consequences) [67],
and whether a clinician intends to perform the prac-
tices) [68]. For our primary outcome, individual level
predictors along the causal pathway will be assessed
(see Table 4). We have decided to only include these for
the primary outcome, and not other outcomes for two
Table 4 Predictors of clinical practices
Data collection
method
Outcome assessment
period/timing
Data source Level data
collected
Analysis
level
PTA, CT, INFO
Cognitions in relation to mild traumatic brain injury related team climate
Team climate
• Participative safety Staff questionnaire (4-item) Baseline/Endpoint Doctors Staff member ED
Nurses
• Support for innovation Staff questionnaire (3-item) Baseline/Endpoint Doctors Staff member ED
Nurses
• Vision Staff questionnaire (4-item) Baseline/Endpoint Doctors Staff member ED
Nurses
• Task orientation Staff questionnaire (3-item) Baseline/Endpoint Doctors Staff member ED
Nurses
Behaviourally specific cognitions
Intention to adhere to recommended practice
• PTA Staff questionnaire (1-item) Baseline/Endpoint Doctors Staff member Staff member
Nurses
• CT Staff questionnaire (1-item) Baseline/Endpoint Doctors Staff member Staff member
• INFO Staff questionnaire (1-item) Baseline/Endpoint Doctors Staff member Staff member
Nurses
PTA only
• Knowledge Staff questionnaire (2-item) Baseline/Endpoint Doctors Staff member Staff member
Nurses
• Beliefs about capabilities Staff questionnaire (3-item) Baseline/Endpoint Doctors Staff member Staff member
Nurses
• Beliefs about consequences Staff questionnaire (3-item) Baseline/Endpoint Doctors Staff member Staff member
Nurses
• Social influences Staff questionnaire (2-item) Baseline/Endpoint Doctors Staff member Staff member
Nurses
• Environmental context and resources Staff questionnaire (3-item) Baseline/Endpoint Doctors Staff member Staff member
Nurses
CT, CT scan-clinical criteria; INFO, provision of patient information; PTA, appropriate PTA screening.
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measure of clinical practice from the medical records
which can be measured for all patients; and 2) to reduce
the responder burden for clinicians.
Proxy measures of clinical practice and predicting fac-
tors are measured using staff questionnaires. The NET
team will prepare the questionnaire packs (including invi-
tation letters, explanatory statements and baseline ques-
tionnaires) and send these to a local survey coordinator,
who will be tasked with the distribution of the packs to
their randomly selected staff members (for example, via
mail or pigeon hole). Non-responders will receive re-
minders verbally or via email, and will be sent a reminder
pack [69]. Questionnaires will be available upon request,
and from the website (http://www.netprogram.org.au/).Figure 2 depicts our conceptual framework, informed
by Frambach and colleagues [70], Greenhalgh and col-
leagues [71] and Michie and colleagues [67]. It shows
the specific factors our intervention will target, listed
within categories (in bold).Patient and cost outcomes Table 5 outlines the patient
and cost outcomes that will be included in the study.
We hypothesise that provision of patient information
containing advice, education, and reassurance upon dis-
charge from the ED reduces anxiety and number of self-
reported symptoms [40]. In addition, we will investigate
whether this leads to improved post-accident function-
ing (return to normal activities including work and
Figure 2 Conceptual framework. CT, CT scan-clinical criteria; HRQoL, health-related quality of life; INFO, provision of patient information; mTBI,
mild traumatic brain injury; PTA, appropriate PTA screening.
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events (for example, re-presentations).
Patient outcomes in the NET-Plus hospitals will be
collected via a computer-assisted telephone interview
by a trained researcher, following consent received via
a local ED staff member. Anxiety will be measured
using the relevant questions in the Hospital Anxiety
and Depression Scale [72,73]. Post-concussive symp-
toms will be measured using the 13-item Rivermead
[74]. HRQoL will be measured using a 12-item short
form health survey (SF-12) and SF-12-based SF6D [75,76].
The SF6D’s six domains - physical functioning, role par-
ticipation, social functioning, bodily pain, mental health,
and vitality - encompass variation in patient outcomes
with respect to anxiety, interference with normal work
and social function due to sleep problems, and physical
functioning. Australian population norms for the SF-36-
based SF6D are now available [77] and the SF6D has pre-
viously been used as a measure of HRQoL in TBI [78].
Data quality assurance
Chart auditors will be trained to identify eligible patients
in the medical record system, and to log data into thesecure web-based system in participating hospitals.
Auditors will assess the same pilot records, and training
will continue until sufficient consistency is achieved.
Auditors will receive a data collection manual with in-
structions (such as definitions and data dictionary). The
web-based database will be designed to minimise errors
(for example, inability to leave particular fields open,
or warning when answer is outside expected range).
Double data entry will be used for all paper-based ques-
tionnaires and returned questionnaires will be checked
for consistent errors or missing data.
Sample size
The primary outcome in the NET trial is appropriate
PTA screening. In the calculation of sample size for this
outcome, adjustment needs to be made for the clustered
nature of the design. The variance inflation factor, or
design effect, used to achieve this is a function of the
average cluster size, variation in cluster size, and the
intra-cluster correlation (ICC) [79].
The assumed ICC was calculated from two sources
reporting ICCs from various datasets [80,81]. We in-
cluded only ICCs for process measures in secondary care
Table 5 Patient and cost outcomes
Data collection method Outcome assessment
period/timing
Data source Level data collected Analysis level
Clinical outcomes and quality of life
▪ Anxiety* CATI questionnaire (7-item) 3-5 month post-discharge Patient Patient Patient
▪ Post-concussive symptoms CATI questionnaire (13-item) 3-5 month post-discharge Patient Patient Patient
▪ Return to normal activities including work CATI questionnaire (2-item) 3-5 month post-discharge Patient Patient Patient
▪ Health-related quality of life CATI questionnaire (12-item) 3-5 month post-discharge,
data collected over last month
Patient Patient Patient
Healthcare utilisation and costs
▪ Medical and surgical services received in
ED/inpatient ward (including CT scan)
Chart audit Retrospectively on a 2 month
period post-intervention
Hospital record Patient Patient
▪ Re-presentation to ED CATI questionnaire (1-item) 3-5 month post-discharge Patient Patient Patient
Chart audit Retrospectively on a 2 month
period post-intervention
Patient Patient Patient
▪ Healthcare visits in relation to mTBI
(GP, brain clinical, other)
CATI questionnaire (3-item) 3-5 month post-discharge; data
collected over last month
Patient Patient Patient
▪ mTBI-related medication use CATI questionnaire (4-item) 3-5 month post-discharge; data
collected over last month
Patient Patient Patient
▪ Direct costs delivering intervention
(intervention group only)
Data abstraction surveys On completion of delivery Admin records Intervention components ED
*Primary outcome. CATI, computer-assisted telephone interview; CT, computed tomography; ED, emergency department; GP, general practitioner; mTBI, mild traumatic brain injury.
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http://www.trialsjournal.com/content/15/1/281settings since empirical research has demonstrated that
ICCs tend to be larger for 1) process measures com-
pared with patient outcomes (median 0.063 versus 0.030,
respectively), and 2) secondary care compared with pri-
mary care (median 0.061 versus 0.045) [63]. Thirty three
ICC estimates for process measures in secondary care
were available, and the median ICC was 0.18. The vari-
ation in cluster size was incorporated into the sample
size calculation through an estimate of the coefficient of
variation, defined as the ratio of the standard deviation
of the cluster sizes to the mean cluster size [79]. The
estimated coefficient of variation of 0.47 was calculated
from annual attendance at EDs across 170 hospitals in
Australia in 2009.
There were limited studies providing estimates of rates
of compliance for our primary outcome [82], and no
studies undertaken in adult populations. We therefore
undertook a retrospective audit of two Australian metro-
politan EDs. The estimated rates of appropriate PTA
screening for patients presenting in these hospitals (with
an initial GCS of 14 or 15) were 0% (95% CI 0% to 14%;
n = 24) in one hospital, and 31% (95% CI 24% to 39%;
n = 164) for a second (which had an mTBI protocol in
place) (Bosch M, McKenzie J, unpublished observations).
We expected that hospitals without a protocol for mTBI
would be more interested in participating in the trial,
and therefore calculated our sample size based on a con-
trol group rate of 10% (that is, closer to the estimated
rate in the hospital with no protocol in place). We wish
to detect an absolute increase in the rate of appropriate
PTA screening of at least 20%. Our rationale for select-
ing a difference of 20% is based on considering the size
of effect required to justify a resource intensive interven-
tion such as NET, and estimates of the effects of local
opinion leaders on professional practice observed across
a range of studies [83].
To detect an absolute increase of 20% in the rate of
appropriate PTA screening (equivalent to an odds ratio
of 3.9, log odds 1.3) (assuming a control group rate of
10%, an ICC of 0.18, coefficient of variation = 0.47, an
average of 30 patient participants per ED, and a 5%
significance level) with 80% power, we will require 15 EDs
per intervention group. A total of 30 EDs will provide 900
patient participants for whom ED staff management will
be assessed. For 900 patient participants, the width of the
95% confidence interval for the observed difference in ap-
propriate PTA screening rates between groups will be ap-
proximately ±14% (equivalent to a width of ±0.51 on the
log odds scale). Allowing for 10% attrition in EDs, we plan
to initially recruit 17 EDs per intervention group.
Power is dependent on the selected parameters, but in
cluster trials is primarily determined by the chosen ICC
and control group rate. Assuming all other parameters
are as defined above, a lower control group rate (forexample, 5%) will result in greater power (87%), while a
higher control group rate (for example, 30%) would re-
sult in less power (60%). A smaller ICC (for example,
0.10) would result in greater power (94%), while a larger
ICC (for example, 0.30) would result in less power
(59%).
Sample size calculations were undertaken using the
module clustersampsi [84] implemented in the statistical
package Stata (StataCorp LP, USA) [85].
Effectiveness analysis
The effectiveness of the intervention on management
outcomes, predictors of management outcomes, and pa-
tient outcomes will be estimated with marginal model-
ling using generalised estimating equations. These
models will appropriately account for correlation of re-
sponses of individuals within EDs. We plan to fit an ex-
changeable correlation structure where responses from
the same ED are assumed to be equally correlated [86].
We will use robust variance estimation which yields
valid standard errors even if the within-cluster correl-
ation has been incorrectly specified [87,88]. For binary
outcomes, a logit link will be used.
Models will include adjustment for minimisation fac-
tors (size (annual presentation rate in 2012), existence of
an mTBI protocol, NET or NET-Plus, and rurality) and
pre-specified potential confounding variables (Figure 3).
The potential confounding variables have been selected
through discussion amongst the investigators and from
published research. All pre-specified confounders will be
included in the models even when no baseline imbalance
exists. In addition, for continuous outcomes which are
collected at both baseline and follow-up (for example,
clinicians’ self-reported cognitions, social and environ-
mental influences in relation to the key behaviours, cog-
nitions about their organisation and team climate) we will
include the baseline measure of the outcome in the model.
Adjustment for the baseline measure of a continuous out-
come yields unbiased estimates of intervention effect in
circumstances where there is baseline imbalance, and has
the benefit of providing the most powerful analysis [89].
Our primary effectiveness analysis will be the model (as
described above) that estimates the intervention effect
on the primary outcome, appropriate PTA screening.
Estimates of intervention effect from these models
with binary outcomes will yield odds ratios. To aid inter-
pretability, we plan to also provide estimates of risk differ-
ences [90]. Estimates of risk differences will be computed
from marginal probabilities estimated from the fitted
logistic models [91].
Missing data for the clinical practice outcomes are likely
to be minimal since eligible patients will be identified and
data extracted through chart audit. Missing data could
arise if EDs choose to withdraw post-randomisation but
Figure 3 Confounders. mTBI, mild traumatic brain injury; NET, Neurotrauma Evidence Translation.
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ing in empty clusters. Accounting for empty clusters
requires strong assumptions to be made about patient
characteristics and outcomes based on ED staff or ED
characteristics. We will attempt to examine the potential
impact of empty clusters on the intervention effects for
the clinical practice outcomes using weights to allow for
patterns of ‘missingness’ [92]. For continuous outcomes,
generalised estimating equations yield unbiased estimates
of intervention effect when 1) data are missing completely
at random, or 2) when the correlation structure is cor-
rectly specified and known covariates that are associated
with the missing data mechanism are included in the
model (missing at random) [93,94]. For the continuous
proxy measures of clinical practice and hypothesised
mediators, we plan to identify potential predictors of
missing data through modelling (for example, [95]), and
include these predictors in the primary analysis model.
We will investigate methods to impute missing outcome
data collected at baseline (for example, baseline behav-
ioural constructs) [96].All estimates of intervention effect will be reported
with 95% confidence intervals. No adjustment will be
made for multiple testing. All tests will be two-sided and
carried out at the 5% level of significance. A full statis-
tical analysis plan will be developed and written prior to
undertaking any data analysis.
Potential confounders at patient level are collected via
chart audit. Potential confounders at the level of staff
members, as well as organisational history of change
[97], organisational learning [98], leadership [99], staff
culture [99] and team tenure [100] will be collected via
self-report surveys. ED structural characteristics will be
measured via a telephone checklist completed by the ED
Director (or delegate).
Process evaluation
Our theory-based evaluation of factors along the pro-
posed causal pathway (see Table 4 and Figure 2) will be
complemented by other components that form part of
our process evaluation [101,102]; these are: 1) an assess-
ment of intervention fidelity (whether the intervention
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(delivery), and whether it reached the target group (re-
ceipt)) [103,104]; 2) perceptions of success of delivery
and receipt [105], and factors that contributed to this
[103]; and 3) perceptions of acceptability and feasibility
of the roll-out of the intervention [106].
Table 6 summarises the main elements included in the
evaluation, methods planned, and indicative measures. A
more detailed description of the fidelity assessment will
be provided in a future publication.
We plan to conduct semi-structured interviews with
ED Directors, local opinion leaders and staff members in
eight intervention hospitals. We will sample for maximumTable 6 Overview of mixed-methods process evaluation
Element Method Indicati
Theory-based evaluation of factors along the
proposed causal pathway
Quantitative Interven
Delivery of intervention components Mixed Interven
Local op
each ho
Stakeho
forth (re
Train-the
Local ed
log-boo
Material
and staf
Control
interven
Director
improve
Receipt and acceptability and feasibility of
intervention elements
Mixed Interven
Local op
endpoin
(in semi
Stakeho
(both re
Train-the
lists; par
Local ed
lists; par
surveys
Material
and staf
Perceptions around successful implementation Qualitative Interven
assessed
Perceptions of factors influencing successful
implementation
Mixed Interven
processe
percept
forth, m
Inclusion
Perceptions of acceptability and feasibility
intervention as ‘package’
Mixed Interven
measure
ED, emergency department; mTBI, mild traumatic brain injury; NET, Neurotrauma Evvariation (for example, size and location of EDs). The
interview guide and analyses will be guided by a theory-
based framework that was used in phase two of this pro-
ject (the interview phase). Analyses and interviewing will
be done concurrently to inform emerging themes. If data
saturation has not been reached after conducting inter-
views in eight hospitals, we will add sites and continue
sampling until data saturation [107].
In addition, a brief checklist-guided structured inter-
view will be conducted by telephone with ED Directors
or delegates to assess sustainability of the changes in
intervention hospitals (for example, plans to integrate a
validated tool into charts).ve measures/details
tion and control group: scales in endpoint surveys (see Table 4)
tion group: detailed assessment of NET intervention delivery
inion leaders: researcher-assessed presence of both opinion leaders in
spital for entire intervention delivery duration
lder meeting: attendance of providers; delivery of messages and so
searcher assessed)
-trainer: observer assessment of intervention components
ucational workshops: education sessions provided assessed via
ks completed by the clinical opinion leaders
s and tools: availability assessed via self-report clinical opinion leaders
f
group: high-level assessment of potential delivery of (non-NET)
tion components assessed via a brief telephone interview with ED
or delegate (for example, was someone in your ED championing
ments/providing education around the management of mTBI patients?)
tion group:
inion leaders: inclusion ‘local opinion leaders’ scale (ORCA) in staff
t surveys; staff perceptions of ‘availability’ and ‘credibility’
-structured interviews)
lder meeting: attendance of key-stakeholders; acceptance of messages
searcher assessed)
-trainer: attendance of local opinion leaders assessed via attendance
ticipant assessment of acceptance of components (participant sheets)
ucational workshops: attendance of local staff assessed via attendance
ticipant acceptance of sessions provided, assessed via scales in endpoint
and semi-structured evaluation interviews
s and tools: availability assessed via self-report of local opinion leaders
f
tion group: Perceptions around the success of the implementation
in semi-structured interviews
tion group: Perceptions around factors influencing the implementation
s (for example, organisational readiness; perceived leadership support;
ions around quality and clarity of evidence and recommendations and so
easured in semi-structured interviews)
of ‘leadership’ scale (ORCA) in staff endpoint surveys
tion group: Perceptions around usefulness and feasibility of roll-out
d in semi-structured interviews
idence Translation; ORCA, organisational readiness to change assessment.
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Pre-recruitment ethical approval of this trial protocol has
been granted by Alfred Health Human Research Ethics
Committee (approval Number 398/12). When participat-
ing hospitals have been identified, local ethics and research
governance procedures will be completed. This will in-
clude a “letter of understanding”, which contains informa-
tion around what the trial entails, what the expectations
are from hospitals and researchers, and the process to
authorise the independent chart auditor to undertake the
data extraction from medical records. The document will
be signed following recruitment, and prior to randomisa-
tion. It will still be possible for EDs to withdraw from the
study at any time should they wish to do so.
Consent procedures will be in line with recent guid-
ance regarding ethical issues in CRTs [54,108], and in-
clude the following.
For all hospitals
ED Directors will be asked to consent to: 1) ED trial ran-
domisation (NET or NET-Plus); 2) delivery of the inter-
vention to their ED; 3) permission to approach staff
members for data collection purposes; 4) extraction of
medical record information by the chart auditor for eli-
gible patients over a 2 month period; and 5) permission
to use this data for the current study and potentially fu-
ture linked studies, with the understanding that all iden-
tifiable information will be removed, unless participants
stated otherwise.
For NET-Plus hospitals
For the hospitals that opt to participate in the NET-Plus
component, ED Directors are requested to, in addition to
the points in the preceding paragraph, also consent to pa-
tients being contacted by telephone by an ED staff mem-
ber post discharge to: 1) ask consent to participate in the
telephone follow-up interview that will be performed by a
trained researcher with experience in follow-up in this
patient group; and 2) to allow the NET researchers to
receive their contact details.
Staff members, intervention delivery
In cluster trials, it is impractical/impossible for researchers
to obtain informed consent from every individual cluster
member to receive the educational intervention before
randomisation; therefore, we applied for a waiver for inter-
vention delivery to staff members. To ensure the decision
is in the cluster’s interest, ED directors will be asked to
consult their staff members prior to their decision to par-
ticipate in this study [54].
Staff members, data collection
For staff members selected to receive written question-
naires, we will use the implied consent principle (that iswhen we receive a completed questionnaire this will
constitute informed consent). This will be clearly ex-
plained in the introduction to the questionnaires.
Return of a blank questionnaire will be considered as
refusal to participate. Staff members invited to the
process evaluation interview over the telephone will be
identified by the local opinion leaders, receive an invi-
tation letter and opt in by returning a consent form to
the researchers.
Patients
NET component The NET component of the trial does
not recruit patients. Data extraction from patient files
will be performed by a trained chart auditor with clin-
ical experience, who is familiar with several medical re-
cords systems, and who will sign a confidentiality
agreement. This person will be authorised by each hos-
pital to do the chart audit, and hence can be considered
part of the circle of care at that hospital. We have
sought a waiver for consenting patients to this part of
the study for the following reasons. First, the chart audi-
tor will identify the patients retrospectively. At this time
they will confirm eligibility, and, for feasibilities reasons,
also collect the outcome data. If consent from patients
had been sought following confirmation of eligibility, this
would have required substantial additional resources.
In addition, this process may have introduced selection
bias, whereby those patients choosing to participate
may have differed from patients who declined. Further-
more, only routinely collected information is extracted,
and the central research team will only have access to
non-identifiable information, which maintains the priv-
acy of the patients. Finally, the intervention is not being
delivered at the level of the patient; patients are only
affected indirectly by the study intervention and there
is limited risk of the intervention affecting their inter-
ests adversely [54,109].
NET-Plus component In NET-Plus hospitals, patients
included in the chart audit who meet the initial inclu-
sion criteria for telephone follow-up (see section: re-
cruitment of patients for follow-up) are contacted by
telephone by an ED staff member post discharge to: 1)
ask consent to participate in the telephone follow-up
interview that will be performed by a trained researcher
with experience in follow-up in this patient group; and
2) to allow the NET researchers to receive their contact
details. The NET team will then send explanatory letters
to the patients who consented to the above, to provide
them with the information regarding the follow-up inter-
view. This letter explains participation in the interview is
entirely voluntary. At the start of the actual interview,
the patients will again be given the opportunity to opt
out of the study, should they wish to do so.
Bosch et al. Trials 2014, 15:281 Page 16 of 20
http://www.trialsjournal.com/content/15/1/281Confidentiality of data
Confidentiality of data will be ensured via the following
processes. All information collected will be entered via a
web-interface into a secure server database. Each user
will have a unique username and will be assigned a role
that will provide them with access to only the informa-
tion they need to see. The database administrator will
have access to the full data, and will sign a privacy state-
ment acknowledging responsibilities and restrictions on
handling identifiable information according to ethics
guidelines.
Patient data, NET component
Independent chart auditors who have been authorised
by the hospitals to collect data will be able to see and
log identifiable information (for example, patient num-
bers and names) in the database. For data quality pur-
poses, patient data need to be re-identifiable. However,
this information will not be visible to study researchers
who will only be able to see “study participant numbers”
(a unique number automatically generated by our data-
base system) and non-identifiable information.
Patient data, NET-Plus component
Only patients who provide full verbal consent to the ED
staff member will be identifiable from information in the
database by the study researchers. Identification of pa-
tients for NET-Plus is necessary for completion of the
patient interview.
Staff data
Survey packs (including a participant identification num-
ber) will be prepared by NET staff, and will be distrib-
uted by a local ED staff member (survey coordinator) in
each hospital. For follow-up purposes, data need to be
re-identifiable. Therefore, the survey coordinator will
have access to names as well as study participant num-
bers. Completed surveys will be returned directly to the
researchers and the data will be entered into the data-
base. Therefore, the survey coordinator will not have
access to the data. Researchers will have access to the
data and study participant numbers, but not identifiable
information.
Economic evaluation
A number of previous studies have estimated the costs
and benefits associated with adherence to various diag-
nostic management strategies for mTBI [110-112]. Stein
and colleagues [112] conducted a modelled cost-utility
analysis comparing selective CT scanning based on the
CCTHR, CT for all patients, skull radiography for all
patients, prolonged ED observation, 24-hour hospital
admission, and no treatment. Smits and colleagues
[111] conducted a modelled cost-utility analysis basedon data from the Computed Tomography in Patients
with Minor Head Injury (CHIP) trial [26] (comparing
selective CT as per the New Orleans Criteria, CCTHR,
and CT in Head Injury Patients (CHIP) criteria) and CT
for no patients. Holmes and colleagues [110] conducted
a modelled cost-utility analysis comparing selective CT
scanning (as per National Institute for Health and Care
Excellence (NICE) guidelines, the CCTHR and various
other guidelines), CT for all patients, and discharge for
all patients without testing. Findings from each of these
studies suggest that – at the mean – selective CT scan-
ning is cost-effective in comparison to other strategies.
However, in interpreting these findings, Holmes and
colleagues [110] noted that “… the cost of CT scanning
is very small compared to the estimated cost of caring
for patients with brain injury worsened by delayed treat-
ment” (page 1,423) and concluded that “… all hospitals
receiving patients with minor head injury should have
unrestricted access to CT scanning for use in conjunc-
tion with evidence based guidelines” (page 1,423). Com-
parisons between alternative criteria for selective CT
suggested that they offer “broadly similar costs and
quality-adjusted life years” [110] (page 1,428), though
adherence to the medium risk CCTHR had the highest
probability of being the most cost-effective strategy in
the study conducted by Holmes and colleagues [110].
Results reported by Stein and colleagues [112] and
Smits and colleagues [111] are broadly consistent with
these findings.
The costs and benefits associated with adherence to
various diagnostic management strategies are clearly
relevant to the question: what is the cost-effectiveness
of an implementation intervention to increase adher-
ence to key recommendations regarding diagnostic
management? However, addressing this question entails
a number of complications that were not addressed in
the studies by Stein and colleagues [112], Smits and col-
leagues [111] and Holmes and colleagues [110]. First,
the potential for cost-effective implementation is predi-
cated on the existence of an evidence-practice gap (see
Table 1). Previously published studies by Stein and col-
leagues [112], Smits and colleagues [111] and Holmes
and colleagues [110] set aside the difficulties associated
with closing the gap between evidence-based recom-
mendations and clinical practice. Statements of cost-
effectiveness taken from these previous studies are
therefore conditional upon the assumption of perfect
adherence to each of the evaluated diagnostic manage-
ment strategies [27]. Second, implementation typically
entails an additional investment that may or may not be
offset by any health gains and/or reductions in health
service utilisation derived from increased adherence to
evidence-based recommendations. The economic evalu-
ation described here will be the first to consider the
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ence due to implementation of key clinical EBCPG rec-
ommendations regarding the ED management of adult
patients with mTBI, and the additional costs (savings)
arising from the implementation intervention.
Specifically, economic evaluations alongside NET
and NET-Plus will be conducted with the aim of quan-
tifying additional costs (savings) and health gains arising
from delivery of the NET implementation intervention in
adult patients (18 years of age or older) with mTBI in
Australia, compared with passive dissemination of the
recommendations/EBCPG. Evaluation of costs and health
gains arising from delivery of the intervention (ex post of
development of the implementation intervention) will be
informative to policy-makers and hospital administrators
considering a wider roll-out of the NET implementation
intervention. Secondary aims will be to determine whether
the incremental treatment costs of the NET intervention
are offset by reductions in health service expenditure (that
is, whether implementation is cost-saving as compared
with existing practice), and to determine whether the
NET intervention dominates existing practice (that is,
less costly but no less effective). The time horizons for
inclusion of relevant costs and consequences for the trial-
based evaluations described here coincide with the final
scheduled follow-up of participants in NET (2 months
post-intervention) and NET-Plus (3 to 5 months post-
discharge for patients treated in the 2 months post-
intervention). The economic evaluation alongside NET
and NET-Plus will take a health sector perspective in iden-
tifying, measuring, and valuing costs and consequences
within the time horizon for each component.
Additional methods for the economic evaluation in-
cluding methods for the identification, measurement
and valuation of outcomes and resource use are de-
scribed in Additional file 2. Results from the economic
evaluation alongside NET will be expressed as add-
itional costs (savings) per patient appropriately screened
for PTA, per patient who received patient information
upon discharge home, and per patient safely discharged.
Results from the economic evaluation alongside NET-
Plus will be expressed as additional costs (savings) per
point difference on anxiety questions of Hospital Anxiety
and Depression Scale at 3 to 5 months post-discharge,
additional costs (savings) per point difference on the
Rivermead Post-concussive symptoms checklist, and
additional costs (savings) per point difference in SF6D
utility index scores.
Discussion
The cluster trial described in this protocol aims to evaluate
the implementation of a targeted theory- and evidence-
informed intervention to improve key evidence-based
recommended practices for the management of mTBIin Australian EDs. To our knowledge this is the first
trial to evaluate this suite of key recommendations. It
addresses calls to use and test theory-driven models of
change from a range of scientific disciplines to enhance
knowledge translation efforts in ED settings [113]. More
broadly, we hope this protocol may assist those who are
undertaking quality improvement studies in emergency
care settings.
Trial status
At the time of submission of this manuscript, recruit-
ment of sites had been completed, and collection of
baseline data had been started; however, data cleaning or
analysis has not commenced. The trial was registered in
the Australian New Zealand Clinical Trials Registry on
12 December 2012 (ACTRN12612001286831).
Publication policy
The results from the trial will be published regardless
of the outcome. Reporting of this trial will adhere to
the relevant, and most up-to-date, CONSORT (Consol-
idated Standards of Reporting Trials) statement [90]
and its relevant extensions [114-116].
Additional files
Additional file 1: Overview of criteria for CT scanning in adults.
Additional file 2: Additional methods for the economic evaluation.
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